References
- Levin B, Bond JH. Colorectal cancer screening: recommendations of the US Preventive Services Task Force. American Gastroenterological Association. Gastroenterology 1996; 111(5):1381–4
- Van Dam J, Bond JH, Sivak MV Jr. Fecal occult blood screening for colorectal cancer. Arch Intern Med 1995; 155(22): 2389–402
- Babb RR. Gastrointestinal complications of nonsteroidal anti-inflammatory drugs. West J Med 1992; 157(4):444–7
- Kwo PY, Tremaine WJ. Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature. Mayo Clin Proc 1995; 70(1):55–61
- Loebl DH, Craig RM, Culic DD, et al. Gastrointestinal blood loss: effect of aspirin, fenoprofen, and acetaminophen in rheumatoid arthritis as determined by sequential gastroscopy and radioactive fecal markers. JAMA 1977; 237(10):976–81
- Bahrt KM, Korman LY, Nashel DJ. Significance of a positive test for occult blood in stools of patients taking antiinflammatory drugs. Arch Intern Med 1984; 144(11):2165–6
- Pye G, Ballantyne KC, Armitage NC, et al. Influence of non-steroidal antiinflammatory drugs on the outcome of faecal occult blood tests in screening for colorectal cancer. Br Med J (Clin Res Ed) 1987; 294(6586):1510–1
- Toribara NW, Sleisenger MH. Screening for colorectal cancer. N Engl J Med 1995; 332(13):861–7